Background Diabetes mellitus (DM) confers an increased risk of mortality in young and middle-aged individuals and in women. It is uncertain, however, whether excess DM mortality continues beyond age 75 years, is related to type of hypoglycemic therapy, and whether women continue to be disproportionately affected by DM into older age. Methods and Findings From the Cardiovascular Health Study, a prospective study of 5,888 adults, we examined 5,372 participants aged 65 y or above without DM (91.2%), 322 with DM treated with oral hypoglycemic agents (OHGAs) (5.5%), and 194 with DM treated with insulin (3.3%). Participants were followed (1989–2001) for total, cardiovascular disease (CVD), coronary heart disease (CHD), and non-CVD/noncancer mortality. Compared with non-DM participants, those treated with OHGAs or insulin had adjusted hazard ratios (HRs) for total mortality of 1.33 (95% confidence interval [CI], 1.10 to 1.62) and 2.04 (95% CI, 1.62 to 2.57); CVD mortality, 1.99 (95% CI, 1.54 to 2.57) and 2.16 (95% CI, 1.54 to 3.03); CHD mortality, 2.47 (95% CI, 1.89 to 3.24) and 2.75 (95% CI, 1.95 to 3.87); and infectious and renal mortality, 1.35 (95% CI, 0.70 to 2.59) and 6.55 (95% CI, 4.18 to 10.26), respectively. The interaction of age (65–74 y versus ≥75 y) with DM was not significant. Women treated with OHGAs had a similar HR for total mortality to men, but a higher HR when treated with insulin. Conclusions DM mortality risk remains high among older adults in the current era of medical care. Mortality risk and type of mortality differ between OHGA and insulin treatment. Women treated with insulin therapy have an especially high mortality risk. Given the high absolute CVD mortality in older people, those with DM warrant aggressive CVD risk factor reduction.
References
[1]
Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, et al. (1998) Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 339: 861–867.
[2]
Lotufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, et al. (2001) Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 161: 242–247.
[3]
Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, et al. (2004) Trends in cardiovascular complications of diabetes. JAMA 292: 2495–2499.
[4]
Fang J, Alderman MH (2006) Impact of the increasing burden of diabetes on acute myocardial infarction in New York city 1990–2000. Diabetes 55: 768–773.
[5]
Gu K, Cowie CC, Harris MI (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281: 1291–1297.
[6]
Thomas RJ, Palumbo PJ, Melton III LJ, Roger VL, Ransom J, et al. (2003) Trends in the mortality burden associated with diabetes mellitus. A population-based study in Rochester, Minn, 1970–1994. Arch Intern Med 163: 445–451.
[7]
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, et al. (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21: 518–524.
[8]
Geiss LS, Herman WH, Smith PJ (1995) Mortality in non-insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, et al., editors. Diabetes in America. 2nd edition. Washington (D. C.): NIH. pp. 233–258. publication 95–1468. pp. .
[9]
Nilsson PM, Johansson SE, Sundquist J (1998) Low educational status is a risk factor for mortality among diabetic people. Diabet Med 15: 213–219.
[10]
Chaturvedi N, Jarrett J, Shipley MJ, Fuller JH (1998) Socioeconomic gradient in morbidity and mortality in people with diabetes: Whitehall study and WHO multinational study of vascular disease in diabetes. BMJ 316: 100–105.
[11]
Songer TJ (1995) Disability in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, et al., editors. Diabetes in America. 2nd edition. Washington (D. C.): NIH. pp. 259–282. publication 95–1468. pp. .
[12]
Todaro JF, Shen BJ, Niaura R, Spiro A, Ward KD (2003) Effect of negative emotions on frequency of coronary heart disease (The Normative Aging Study). Am J Cardiol 92: 901–906.
[13]
Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 26: 2822–2828.
[14]
Rockwood K, Stolee P, McDowell I (1996) Factors associated with institutionalization of older people in Canada: Testing a multifactorial definition of frailty. J Am Geriatr Soc 44: 578–582.
[15]
Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, et al. (2002) Cardiovascular Health Study. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med 162: 2333–2341.
Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM (2002) Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105: 2595–2599.
[18]
Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, et al. (1991) The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1: 263–276.
[19]
Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, et al. (1992) Assessing the use of medications in the elderly: Methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 6: 683–692.
[20]
Cushman M, Cornell ES, Howard PR, Boville EG, Tracy RP (1995) Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41: 264–270.
[21]
Orme JG, Reis J, Herz E (1986) Factorial and discriminant validity of the Center for Epidemiologic Studies Depression (CES-D) Scale. J Clinic Psychol 42: 28–33.
[22]
Tierney MC, Szalai JP, Dunn E, Geslani D, McDowell I (2000) Prediction of probable Alzheimer disease in patients with symptoms suggestive of memory impairment. Value of the Mini-Mental State Examination. Arch Fam Med 9: 527–532.
[23]
Swan GE, Carmelli D, LaRue A (1995) Performance on the digit symbol substitution test and 5-year mortality in the Western Collaborative Group Study. Am J Epidemiol 141: 32–40.
[24]
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, et al. (2001) Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56: M146–156.
[25]
Taylor HL, Jacobs DR Jr, Shucker B, Knudsen J, Leon AS Pereira MA, FitzGerald SJ, Gregg EW, Joswiak ML, Ryan WJ, et al., editors. (1997) Minnesota leisure-time physical activity questionnaire (1993). Medicine and science in sports and exercise 29(Suppl): S62–S72. A collection of physical activity questionnaires for health-related research.
[26]
Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL (1991) Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 265: 627–631.
[27]
Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans JH (1988) Mortality among diabetics in a national sample. Am J Epidemiol 128: 389–401.
[28]
Barrett-Connor E, Khaw K-T (1988) Diabetes mellitus: An independent risk factor for stroke? Am J Epidemiol 128: 116–123.
[29]
Ottenbacher KJ, Ostir GV, Peek MK, Markides KS (2004) Diabetes mellitus as a risk factor for stroke incidence and mortality in Mexican American older adults. J Gerontol A Biol Sci Med Sci 59: M640–645.
[30]
Bertoni AG, Krop JS, Anderson GF, Brancati FL (2002) Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 25: 471–475.
[31]
Smith NL, Savage PJ, Heckbert SR, Barzilay JI, Bittner VA, et al. (2002) Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: The Cardiovascular Health Study. J Am Geriat Soc 50: 416–423.
